|Articles|June 15, 2021
Analyzing SARS-CoV-2 Drugs Remdesivir and GS-441524
Author(s)YMC Europe GmbH
A fast separation of remdesivir and its active metabolite GS-441524 for the treatment of COVID-19 is obtained in only 3 minutes using a YMC-Triart C18 UHPLC column.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Waters Completes Combination with BD Biosciences and Diagnostic Solutions Businesses
2
Volatile Organic Compound Profiling of Commercial Kombucha Using GC-TOF-MS and GC×GC-TOF-MS
3
Chromatography-Based Metabolomic Insights for Safer Kimchi Fermentation
4
A Question of Balance? Part III: Weighing Isn’t an Uncertain Process, Is It?
5